Our project based on early detection of congenital heart defects began its journey in 2020.

Master of Engineering and IESE Business School executive education program alumni. A seasoned executive with a background as a former board member at prominent life sciences and healthcare companies in Poland, including Neuca and PZU Zdrowie. Bringing international expertise in M&A, business development and consulting, recently served as a dedicated industry partner at Deloitte Digital.

Has over 12 years of experience in marketing, working with pharmaceutical and FMCG corporations such as Adamed, Aflofarm, KRKA, and RECKITT BENCKISER. He is also a member of the Supervisory Board of Medical Clinic Remedium. With experience in the public and private sectors.

Experienced sales strategist with expertise in the medical and insurance industries. He has worked at companies such as Bor-Pol, Exemed, BellyOn, and Grupa MAK-STBU. He has a proven track record of success in implementing innovative medical solutions and is a licensed insurance broker.

Founder and executive in various companies, for the last 6 years associated with the technology industry, responsible for the creation and implementation of products on the market.

Full Professor at the Medical University of Łódź and serves as the Head of the Department of Obstetrics and Perinatology at the same institution. Additionally, hecurrently holds the position of Head of the Delivery Room at the Institute of Centrum Zdrowia Matki Polki.

Jagiellonian University. Member of the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), involved in developing global guidelines, and recognized by TIME magazine for his original solution Fetal Heart VR.

Head of the Department and Clinics of Pediatric Cardiology and Congenital Heart Defects at the Medical University of Gdańsk. He mainly deals with minimally invasive, percutaneous techniques for the treatment of heart defects. He is an expert in the implementation of these technologies.